Viewing Study NCT06430905

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:27 AM
Ignite Modification Date: 2026-02-21 @ 12:55 PM
Study NCT ID: NCT06430905
Status: TERMINATED
Last Update Posted: 2025-11-18
First Post: 2024-05-17
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Safety, Reactogenicity and Immunogenicity of HB-502 and HB-501 Versus Placebo in People With HIV on Suppressive ART
Sponsor: Hookipa Biotech GmbH
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Human Immunodeficiency Virus (HIV) Infection View
Keywords:

Keywords

Keyword Brief Keyword Text View
None human immunodeficiency virus View
None HIV View
None vaccine View
None immunotherapy View
None arenavirus View
None genetic vector View
None antiretroviral therapy View
None ART View